News
Real-world data confirm the utility of a real-time, blood-sensing capsule to help triage patients with suspected upper ...
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results